
molecular & thoracic pathologist @mskcancercenter alum: @vumedicine @stanford @ucsf 🇺🇸🇰🇷🏳️🌈
New York & San Francisco
Joined November 2013
- Tweets465
- Following341
- Followers502
- Likes484
Pinned Tweet
Please check out our latest review on rare lung cancer subtypes! @MSKPathology #mskimpact #mskfusion #mskaccess
In a Review now published online, Guilherme Harada, Soo-Ryum Yang, @emilianoCocco2 and @alexdrilon discuss some molecular subtypes of #lungcancer that, despite occurring in <5% of patients with this cancer type, affect a considerable number of individuals nature.com/articles/s41571-0…
🔬A #WCLC26 session, chaired by Dr. @sooryumyang, will explore bench-to-bedside science, case-based learning, and audience engagement.
Read a preview in ILCN: ilcn.org/education-session-t… #LCSM
Pls join us at ASCO! Great content and real-world clinical cases 🧬🩸💊🩻
🫁 Precision oncology starts with accurate HER2 testing in NSCLC. Strengthen your approach to identifying eligible patients, tailoring therapy, and collaborating across the multidisciplinary care team. 🔍 mdsc.pe/4cxuHqD
Pls join us at #TTLC26!
🔍 Accurate HER2 testing matters. 🧬 Explore targeted therapies for HER2-mutated NSCLC, 🩺 tailor treatment strategies to individual patients, and 🤝 engage multidisciplinary teams and patients in shared decision-making across the care continuum. ➡️ bit.ly/3Zqwrfn
Soo-Ryum (Stew) Yang MD retweeted
Beyond the Genome: Exploring New Frontiers in NSCLC Management @sooryumyang @MSKCancerCenter @gotoPER #gotoPER #lcsm #oncology
onclive.com/view/beyond-the-…
Soo-Ryum (Stew) Yang MD retweeted
When you FINALLY meet the mysterious molecular guy behind the microscope 🔬! @sooryumyang in the flesh! #nyl25 @MSKCancerCenter @MSKPathology
THANK YOU for teaching me , understanding urgency & putting pts 1st 🥹 ( we were mid case discussion and paused for this selfie) 💁🏽♀️
Soo-Ryum (Stew) Yang MD retweeted
Always great spending time with my friend & colleague @sooryumyang!
We discussed clinical strategies around c-MET IHC testing and what they mean for our patients.
Big thanks to @Pathologists for letting this medical oncologist join!
Soo-Ryum (Stew) Yang MD retweeted
What should young patients ask about their lung cancer pathology?
Dr. @sooryumyang breaks it down at @cure_today’s FIRST Young-Onset Lung Cancer Summit.
Don’t miss it—join us! Register below👇🏽
globalmeet.webcasts.com/star…
One more week until the FIRST @cure_today Young-Onset Lung Cancer Summit!
🗓️ Saturday, April 26
⏰ 10 AM CT
Excited to welcome these two amazing multidisciplinary colleagues of mine!!
Register here:
globalmeet.webcasts.com/star…
Soo-Ryum (Stew) Yang MD retweeted
Final day of #TTLC25!
☕ Kick off your morning in the Mariner’s Ballroom as we dive into all things HER2+ NSCLC!!
@MedscapeLIVE @MedscapeOnc @tnewsomdavis @sooryumyang @IASLC
Soo-Ryum (Stew) Yang MD retweeted
Join @tnewsomdavis, @sooryumyang, & me for @MedscapeOnc’s Live Event!
🎙️Educating, Empowering, & Engaging: A Focus on HER2-Activating Mutations in NSCLC
📅 Saturday, 2/22
⏰ 7–8 AM PT
📍 Hyatt Regency Huntington Beach
events.medscapelive.org/ereg…
🧬 Explore evolving treatments for NSCLC with HER2 mutations! 🩺 Gain confidence in biomarker interpretation, personalized care plans, and tackling barriers to care. 📍 Learn more: ms.spr.ly/6011UrKkP @lungoncdoc #NSCLC #OncologyInnovation
Soo-Ryum (Stew) Yang MD retweeted
One of the most popular webinars in our on-demand education catalog is about oncogenic RET fusions and features speaker @sooryumyang of @MSKCancerCenter. It's free for AMP members, $29 for nonmembers and offers continuing education credit: educate.amp.org/local/catalo…
Soo-Ryum (Stew) Yang MD retweeted
Please join us tomorrow morning, November 13 at 11 am ET for the @ISIMMweb monthly webinar.
@sooryumyang from @MSKPathology is presenting "Predictive Immunohistochemical Biomarkers in NSCLC."
Register here: us02web.zoom.us/webinar/regi…
Share widely!
Please vote for our case!! You know it’s a good case when you have a multidisciplinary collaboration between MD Anderson and Memorial Sloan Kettering! 🙏🏻🫁🧬💊🔬
Lots of excitement with the @IASLC educational Amazing Case Race!
Be sure to vote for your favorite one! #WCLC24 @sooryumyang @ChristianRolfo @RManochakian
form.jotform.com/24218572176…
Please join me and Dr. Jamie Chaft as we explore the latest updates in actionable biomarkers in early-stage NSCLC this Monday, September 9, 2024 at 12:30 PM PDT (Room: 33ABC) #WCLC24
Soo-Ryum (Stew) Yang MD retweeted
(Unofficial) @IASLC Academy meet up is already happening!
So grateful for these two physician friends of mine! @sooryumyang @FawziAbuRous #WCLC24
Soo-Ryum (Stew) Yang MD retweeted
Please join me and Dr. Jonathan Goldman as we discuss important updates in EGFR biomarker testing and treatment for advanced and early-stage NSCLC. @EGFRResisters @TheUSCAP
🧬 Dive into the clinical implications of EGFR mutations in NSCLC. Learn to evaluate mutational status and use it to guide therapy plans. Enhance your diagnostic and treatment decisions through effective communication! 🎯 Join @sooryumyang & other experts: ms.spr.ly/6013Y2a0h
Soo-Ryum (Stew) Yang MD retweeted
Application are open for the ‘26-‘27 #Cytopathology fellowship @MSKPathology.
We offer high volume exposure to diverse specimens, hands on training in US-guided FNA & dedicated research time
Learn more & apply @ ➡ bit.ly/3oxqTR5
DM me with ?? or for more info.
Soo-Ryum (Stew) Yang MD retweeted
Today, we celebrate the anniversary of the monumental marriage equality ruling of Obergefell v. Hodges.
This case moved our country forward, and was made possible because of the courageous couples and advocates in the LGBTQI+ community who fought for these hard-won rights.
Please join me and Dr. Jonathan Goldman as we discuss important updates in EGFR biomarker testing and treatment for advanced and early-stage NSCLC. @EGFRResisters @TheUSCAP
🧬 Dive into the clinical implications of EGFR mutations in NSCLC. Learn to evaluate mutational status and use it to guide therapy plans. Enhance your diagnostic and treatment decisions through effective communication! 🎯 Join @sooryumyang & other experts: ms.spr.ly/6013Y2a0h
Soo-Ryum (Stew) Yang MD retweeted
🚨It's Friday and time for another FDA approval!
👉FDA grants accelerated approval to adagrasib + cetuximab for KRAS G12C-mutated colorectal cancer #Precisionmedicine @SarahCannonDocs @bmsnews 🧬🎯
Link to FDA approval
fda.gov/drugs/resources-info…
Link to @NEJM
nejm.org/doi/full/10.1056/NE…






































